Cefonax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefonax

What is Cefonax?

Property Description
Active ingredient Cefadroxil (as monohydrate)
Form Capsule, Tablet, Oral Suspension
Pharmacological class First-Generation Cephalosporin Antibiotic
Common use Treatment of susceptible Bacterial Infections
Origin Semisynthetic

Cefonax is a brand name for the active pharmaceutical ingredient Cefadroxil, which is a semisynthetic beta-lactam antibiotic belonging to the drug class of first-generation cephalosporins. This medication is classified as an antibacterial drug intended for the systemic treatment of bacterial infections and is strictly available by prescription-only status. The active ingredient, Cefadroxil, is clinically recognized for its favorable absorption profile, a key differentiating factor that often permits less frequent dosing compared to other closely related oral cephalosporins.


Composition and Available Forms

The core composition of Cefonax features the active substance Cefadroxil, typically formulated as the acid-stable Cefadroxil monohydrate. As a single-ingredient product with a semisynthetic origin, its composition focuses entirely on the antibacterial agent. Cefonax is supplied in multiple common dosage forms for oral administration, including the solid capsule or tablet, and an oral powder for reconstitution, which is used to create a liquid oral suspension. The availability of the liquid form makes it particularly useful for pediatric patients, where ease of swallowing is a critical differentiating factor.


Mechanism and General Purpose

Cefonax functions as a powerful bactericidal agent, meaning its primary purpose is to directly kill susceptible bacteria rather than simply inhibiting their growth. The fundamental mechanism involves the irreversible inhibition of bacterial cell-wall synthesis. This process works by targeting the proteins essential for building the bacteria's protective outer shell. This action makes the drug highly effective against pathogenic organisms, primarily susceptible Gram-positive bacteria, thereby working to resolve the underlying bacterial infection. This confirms that the drug has no efficacy against viruses, such as those causing the common cold, a distinction that is medically essential for appropriate use.

What side effects are possible with Cefonax?

Possible side effects and safety information

The safety profile for Cefadroxil (Cefonax) is formally classified by regulatory authorities based on the frequency and the physiological systems affected by documented adverse reactions.

Adverse Reaction Scope

Side effects are primarily classified into Common occurrences and less frequent, but clinically important, Rare events. Common reactions, affecting the Gastrointestinal Disorders system, include diarrhea, nausea, and vomiting. Reactions affecting the Skin and Subcutaneous Tissue Disorders system, such as rash and pruritus (itching), are also frequently reported in official labeling.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Diarrhea, Nausea, Vomiting
Skin Disorders Rash, Pruritus

Serious Adverse Reactions and Safety Constraints

The official labeling documents rare but serious adverse reactions. These include severe hypersensitivity reactions, such as anaphylaxis and angioedema, and Antibiotic-Associated Colitis, including life-threatening pseudomembranous colitis. Regulatory documents note that C. difficile associated diarrhea can occur during or after the completion of treatment.

Cefonax is contraindicated in individuals with a known severe allergy to cephalosporin antibiotics due to the risk of severe allergic reaction. Additionally, specific caution is required for use in patients with a history of penicillin allergy due to the potential for cross-hypersensitivity.

Population-specific safety considerations mandate that the dosage be carefully managed in individuals with markedly impaired renal function to prevent drug accumulation. The drug also carries a high-level caution regarding concurrent use with other nephrotoxic drugs due to the potential for increased renal toxicity, as defined by regulatory documents.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Cefonax

Overdose Scope

Documented overdose presentations: Manifestations of acute toxicity include central nervous system effects such as seizures and other neurological symptoms. Gastrointestinal effects like nausea and vomiting are also listed.

Physiological systems affected: Primary systems affected include the Central Nervous System (CNS), Cardiovascular System (in acute reactions), and Renal System (risk of dysfunction/nephropathy).

Dose-related or exposure-related factors: The risk of severe neurological symptoms is implicated in cases of high-dose exposure or in individuals with impaired kidney function due to drug accumulation.

When immediate medical help is required: Immediate calling of emergency services (911) is required if the victim has collapsed, experienced a seizure, has trouble breathing, or can't be awakened. Immediate medical attention is required for suspected overdose.

Overdose Classifications (High-Level)

Severity classification: Overdose may result in life-threatening outcomes, specifically citing the risk of seizures and severe acute hypersensitivity reactions leading to anaphylaxis.

Official overdose statements:

  • Neurological toxicity, including seizures, is a documented risk, especially when high drug concentrations occur in patients with renal impairment.
  • Management of acute overdose requires symptomatic and supportive treatment and may necessitate procedural monitoring of renal function.

Connection to the overall overdose profile: Regulatory documents define the Cefonax overdose profile based on acute toxic effects and the potential for systemic hypersensitivity. The profile explicitly mandates conditions—such as seizures or collapse—under which users must contact emergency services immediately. Management instructions are limited to general procedural steps, confirming that the approach is symptomatic and supportive as dictated by official labeling.

Therapeutic Uses of Cefonax

Cefonax (cefotaxime) is a medication used in situations involving certain distressing symptoms associated with bacterial infections. It is applied in clinical settings that involve acute or unstable symptom patterns across multiple organ systems. It is commonly used to help with providing supportive relief that may assist patients with coping more steadily during symptomatic phases.

Areas of Use

This medication is applied across domains where additional symptomatic support is needed, addressing conditions associated with acute or disruptive episodes such as lower respiratory tract infections, urinary tract infections, central nervous system infections like meningitis, skin and soft tissue infections, and septicemia.

  • Addressing Symptoms Related to Systemic Discomfort: This domain covers conditions associated with acute or disruptive episodes where symptoms related to systemic imbalance may become more noticeable. Cefonax is commonly used to help with easing the overall symptom load and generally supports the patient during these phases of increased physiological distress. It is applied in contexts where additional support for symptom management is needed.

  • Support for Symptoms Causing Functional Strain: Cefonax is helpful in situations requiring additional symptomatic assistance when symptoms create noticeable physiological strain. Applied during phases when symptoms become temporarily overwhelming, it supports the patient during difficult episodes by easing distress. “It plays a role in managing symptoms that interfere with daily comfort and stability.”

Quick Fact: Relief for Acute Discomfort It is relevant in areas where short-term symptom management is appropriate, used when groups of symptoms appear suddenly or fluctuate.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefonax? (Cefadroxil)

Official regulatory information defines specific population eligibility rules for Cefonax (Cefadroxil) based on allergies, age, and health status.

Contraindicated Populations

Cefonax is contraindicated and must not be used by patients with a known hypersensitivity to cephalosporins or a history of severe allergic reactions to penicillins or other beta-lactam antibiotics. This is an absolute exclusion established across regulatory documents.

Restricted and Conditional Use

Population Group Regulatory Status and Limitation
Impaired Renal Function Use with caution; dosage adjustment is required for patients with markedly impaired renal function (Creatinine Clearance < 50 mL/min/1.73 m^2).
Pregnancy Use is limited to scenarios where it is clearly needed; not studied for labor and delivery (FDA Category B).
Lactation Caution should be exercised, as the drug is excreted into human breast milk.
Children under 6 years The 500 mg capsule formulation is not recommended for this age group.

Age-Based Eligibility

Cefonax is approved for use in adults and pediatric patients for susceptible infections. Geriatric patients are eligible, but caution in dose selection is required, often necessitating monitoring of kidney function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines documented interactions between Cefonax (a cephalosporin antibiotic) and other medicinal products, foods, or laboratory tests, as defined in official regulatory documents. This information serves to inform healthcare decisions and should not be used as a substitute for professional medical advice.


Documented Drug-Drug and Other Interactions

Interacting Product Category Potential Effect and Constraint
Probenecid (Uricosuric) Inhibits the renal excretion of Cefonax, leading to elevated and prolonged drug levels in the bloodstream. Co-administration is generally not recommended due to the potential for increased systemic exposure.
Calcium-Containing Solutions (IV) Risk of precipitation when administered simultaneously via the intravenous route. This physical incompatibility requires that Cefonax is not administered concurrently with calcium-containing IV solutions.
Anticoagulants Cefonax, similar to other cephalosporins, has been associated with a potential fall in prothrombin activity. Close monitoring of prothrombin time (PT) or International Normalized Ratio (INR) is necessary for patients at risk, and Vitamin K administration may be required.

Interference with Laboratory Tests

Cefonax may cause false-positive results in certain diagnostic tests. This includes false-positive reactions for glucose in the urine when using copper-reduction methods (e.g., Benedict's solution or Fehling's solution). It may also lead to a false-positive direct Coombs' test result. Healthcare providers should be aware of this potential interference when interpreting lab results.

Mechanism of Action

How Cefonax Works (Mechanism of Action)

Cefonax (Cefadroxil) employs a bactericidal mechanism, defined by its highly selective action against bacterial pathogens. The drug functions as an irreversible inhibitor of bacterial enzymes known as Penicillin-Binding Proteins (PBPs). Specifically, Cefadroxil targets the transpeptidases within the bacterial cell membrane, which are essential for the final cross-linking of peptidoglycan strands.

By forming a stable, covalent bond with the active site of these PBPs, Cefadroxil permanently deactivates the enzymes, thereby halting the construction of the rigid bacterial cell wall. This failure in synthesis results in a defective and fragile structure that cannot withstand the high internal osmotic pressure of the cell. The resulting force causes the rapid rupture (lysis) of the bacterial cell, initiating a bactericidal cascade that reduces the pathogen load.

This mechanism is selective, targeting structures (PBPs) absent in human cells. The mechanism is constrained by bacterial resistance, primarily through the production of beta-lactamase enzymes, which chemically inactivate Cefadroxil by hydrolyzing its beta-lactam ring.

Dosage and Administration Information

How to Use Cefonax

This section describes the administration and dosing patterns for Cefonax, which contains the active substance Cefadroxil.


Administration Scope

Property Instruction
Route of Administration The medication is approved for Oral (PO) use only.
Dosing Schedule Adult doses are typically 1 g to 2 g per day, administered as a single daily dose or in divided doses. The maximum labeled dose is 4 g per day.
Timing in Relation to Meals Dosing may be taken without regard to meals. Administration with food may help diminish potential gastrointestinal complaints.
Preparation Requirements The powder for oral suspension must be reconstituted with water; the finished suspension must be shaken well before each dose is measured.

Procedural and Course Instructions

  • Course Duration: The medication must be taken for the full prescribed length of time as directed. For infections involving beta-hemolytic streptococci, the minimum duration of therapy is 10 days.
  • Dose Adjustment: Dosage must be adjusted in adults with impaired renal function (creatinine clearance leq 50 mL/min). This adjustment involves an initial 1 g dose followed by extended-interval maintenance doses of 500 mg (e.g., every 12 to 36 hours).
  • Missed Dose: If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose, in which case the missed dose must be skipped. A double dose should never be taken.

Connection to the Overall Use Protocol

These instructions define the standardized oral administration protocol by establishing the precise daily dose range, the required frequency (once or twice daily), and the minimum duration of the course. The protocol mandates dose modification based on renal function and provides specific guidance for the correct preparation and timing of the medication intake.

Recent Clinical Evidence

Research evidence / Overview of studies for Cefonax


Cefonax for Treating Bacterial Infections

The medicine Cefonax has been studied through various types of research, primarily focusing on its evaluation in infections caused by different types of bacteria. Most of the information comes from studies where researchers compare the outcomes associated with Cefonax to either a placebo (an inactive substance) or to another standard approach.

These studies generally suggest that research has investigated outcomes regarding the severity and duration of certain bacterial infections. For instance, for infections of the lower respiratory tract (such as pneumonia or bronchitis), research indicates that Cefonax has been studied in relation to the bacteria responsible. The findings from these studies often suggest that the medicine was examined in these specific infections.

However, the research findings are not always the same across all infections. For urinary tract infections (UTIs), studies have also explored Cefonax's role. While some findings indicate it has been investigated, the evidence base for its use in all types of UTIs is still being gathered and understood. Similarly, in the context of skin and soft tissue infections, research has investigated Cefonax, with suggestions that it has been studied in relation to certain bacterial strains.


Cefonax in Specific Patient Groups

Research studies sometimes look at how an investigational medicine performs in different groups of people. For Cefonax, information about its use in certain specific patient groups is more limited compared to the general adult population.

For example, studies exploring the use of Cefonax in the pediatric population (children) are fewer, and they often focus on a narrow range of infections. The research so far suggests that Cefonax has been studied for certain bacterial infections in children, but the evidence base is smaller and less comprehensive than that for adults. Therefore, how Cefonax's use relates to other studied approaches in the body of a child compared to an adult is not as thoroughly investigated, and findings are often preliminary.

A notable area for further research is the lack of large, focused studies on these special populations, including older adults. More research is needed to better understand the findings of studies on Cefonax's use and how its results compare to other treatments for specific bacterial infections in these groups.

Key Studies & References

  1. Cefotaxime: A Reappraisal in Lower Respiratory Tract Infections

Frequently Asked Questions (FAQ)

Common questions about Cefonax (FAQ)


Q: How quickly does Cefonax typically start working?

Cefadroxil, the active ingredient in Cefonax, is absorbed quickly after being taken orally. Official pharmacological documentation indicates that the concentration of the medicine in the bloodstream generally reaches its highest levels about 1.5 to 2.0 hours following the dose.


Q: Is Cefonax known to cause drowsiness?

The official product information lists dizziness, headache, and sleeplessness as rare reactions that can affect the nervous system. Drowsiness or fatigue are noted as very rare events in regulatory reporting. The most common side effects are generally related to the stomach or skin.


Q: What is the difference between Cefonax and other similar antibiotics?

Cefonax is a first-generation cephalosporin antibiotic. Pharmacological studies indicate that Cefadroxil has a favorable absorption profile compared to some other related oral cephalosporins, which is a factor that supports less frequent dosing.


Q: Can Cefonax cause issues with blood sugar levels?

Official labeling states that Cefonax may interfere with certain laboratory tests. Specifically, it can cause false-positive results for glucose in the urine when tests using copper-reduction methods are used. This interference is a documented effect on certain lab results.


Q: Is Cefonax a Schedule H or similar controlled substance?

Cefonax (Cefadroxil) is classified as a prescription-only medicine (POM). According to the NIH and FDA drug status classifications, it is not listed as a controlled substance under the US DEA schedules or similar international classifications.


Q: What are the symptoms of an overdose of Cefonax?

Official prescribing information for overdose generally describes the need for supportive and symptomatic management. It is also noted that Cefadroxil is a drug that can be removed from the body through a process called hemodialysis.


Q: Are there special considerations for people with liver conditions taking Cefonax?

Regulatory documents primarily focus on the need for dosage adjustment in patients with impaired kidney function. While rare reactions affecting the liver, such as temporary elevations in liver enzymes, have been noted in reporting, there are no specific blanket dosage adjustments mandated for pre-existing liver conditions.


Q: Is there a generic version of Cefonax available?

Yes, Cefonax is the brand name for the active ingredient Cefadroxil. The FDA maintains an official list of approved generic products that are considered therapeutically equivalent to the brand-name product.


Q: Can Cefonax affect the results of blood tests?

Yes, official labeling confirms that Cefonax can interfere with certain lab results. It is known to potentially cause a false-positive direct Coombs’ test result and can also affect some methods used to test for glucose in the urine.


Q: Does Cefonax interact with birth control pills?

While Cefadroxil's official labeling may not list oral contraceptives as a formal interaction, some medical literature suggests that antibiotics in this class could potentially affect the effectiveness of estrogen-containing birth control pills. The potential for this interaction is a topic that can be reviewed with a healthcare professional.


Q: Is it normal to feel tired when taking Cefonax?

Feeling tired, or fatigue, is listed in regulatory reporting as a very rare adverse event associated with the medicine. Common side effects are usually limited to the digestive system (like diarrhea) and skin (like rash).


Q: Is Cefonax a narrow-spectrum or broad-spectrum medicine?

Cefonax (Cefadroxil) is classified as a first-generation cephalosporin. This class is typically most active against Gram-positive bacteria, meaning it is often classified as having a narrower spectrum of activity compared to newer cephalosporins.


Q: Can Cefonax affect your ability to drive or operate machinery?

Since rare side effects reported include dizziness and nervousness, official documents mention the need for caution related to performing skilled tasks like driving or operating machinery. This is based on the potential for known side effects to affect individual performance.


Q: What is the duration of action for Cefonax after a dose?

The half-life of Cefadroxil in the body is approximately 1.5 hours in individuals with normal kidney function. Measurable levels of the medication have been reported to remain present in the body for up to 12 hours after a single dose.


Q: Can Cefonax be crushed or split?

Official administration instructions for the solid forms of Cefonax (tablets or capsules) do not include directions for crushing, cutting, or splitting the medication. Instructions only address the reconstitution of the powder used to make the liquid suspension.


Q: Can Cefonax be taken during pregnancy, according to official classification?

Cefonax is classified as FDA Pregnancy Category B. This means that studies in animals have generally not shown a risk to the fetus. The official documentation states its use during pregnancy is limited to when it is considered clearly needed.


Q: What should I do if I forget to take a dose of Cefonax?

Official administration protocols define specific steps for a missed dose, based on timing relative to the next dose. These protocols are in place to help ensure consistent drug levels are maintained to complete the full course of therapy.


Q: Does Cefonax interact with supplements containing iron or calcium?

The official interaction section documents a risk of incompatibility with calcium-containing solutions when they are administered intravenously. There is no explicit mention in the official labeling regarding interactions with oral supplements containing iron or calcium.


Q: What are the officially documented rare side effects of Cefonax?

Rare but serious reactions documented in the official labeling include severe hypersensitivity reactions like anaphylaxis and angioedema, a serum sickness-like reaction, interstitial nephritis (a kidney issue), and a potential fall in prothrombin activity (a clotting factor).

How should Cefonax be stored and disposed of?

How to Store and Dispose of Cefonax (Cefadroxil)

Official regulations define specific storage requirements for Cefonax (Cefadroxil) based on its form to maintain potency and safety.


Storage Conditions

Dosage Form Required Temperature Stability/Protection Constraints
Capsules/Tablets Controlled room temperature (20 C to 25 C) Keep container tightly closed; store away from heat, moisture, and light.
Oral Suspension (Liquid) Refrigerated (2 C to 8 C) Do not freeze; discard after 14 days of reconstitution.

Disposal and Safety

All forms of Cefonax must be stored out of the sight and reach of children. Unused or expired medication should be disposed of properly, following official guidance, and must not be thrown away via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefonax found in:

A-Z Index: